Tracking HIV, TB, and related health issues in Southern Africa
International epidemiology Databases to Evaluate AIDS (IeDEA) Southern Africa.
['FUNDING_U01'] · UNIVERSITAT BERN · NIH-11401341
This project links clinic and hospital records across Southern Africa to learn how people with HIV, TB, and related conditions are doing and how care can be improved.
Quick facts
| Phase | ['FUNDING_U01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITAT BERN (nih funded) |
| Locations | 1 site (Bern, SWITZERLAND) |
| Trial ID | NIH-11401341 on ClinicalTrials.gov |
What this research studies
This project brings together hospital and clinic records from across Southern Africa so researchers can follow people with HIV, TB, and other infections over time. It includes adults, pregnant people, infants, children, and adolescents, and adds new groups like pre-exposure prophylaxis (PrEP) users and cancer/HIV match cohorts. The team will look at the effects of COVID-19 on health services, track noncommunicable diseases, mental health and substance use, and use digital tools and open-data methods to share findings. If you take part, your clinic data may be included in regional datasets that help guide prevention, diagnosis, and long-term care.
Who could benefit from this research
Good fit: Ideal candidates are people receiving care for HIV or TB (including pregnant people, children, adolescents, and adults) or people in PrEP programs who receive care at participating clinics in Southern Africa.
Not a fit: People living outside Southern Africa, those not seen at participating clinics, or those who do not want their health records used would not be included and would not directly benefit from participation.
Why it matters
Potential benefit: If successful, this work could help clinics and governments improve prevention, diagnosis, and long-term care for people living with HIV, TB, and related conditions.
How similar studies have performed: Previous IeDEA regional collaborations have produced influential findings about HIV care outcomes, and this effort builds on that experience while expanding to TB, cancer links, PrEP cohorts, and COVID-19 impacts.
Where this research is happening
Bern, SWITZERLAND
- UNIVERSITAT BERN — Bern, SWITZERLAND (ACTIVE)
Researchers
- Principal investigator: ROHNER, ELIANE — UNIVERSITAT BERN
- Study coordinator: ROHNER, ELIANE
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Acquired Immune Deficiency Syndrome, Acquired Immune Deficiency Syndrome Virus, Acquired Immunodeficiency Syndrome, Acquired Immunodeficiency Syndrome Virus